Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:13 AM
Ignite Modification Date:
2025-12-25 @ 3:13 AM
NCT ID:
NCT06623305
Eligibility Criteria:
Inclusion Criteria:
* Admitted to oncology unit, PICU, or on an alternate acute care unit.
* Diagnosis:
* Following diagnoses until achieve count recover (ANC≥500), the patient has no clinical signs of mucositis, or is discharged i. ALL interim-maintenance high dose Methotrexate ii. ALL with trisomy 21 receiving high dose Methotrexate iii. AML iv. Neuroblastoma (excluding admissions for antibody treatment) v. Burkitt lymphoma vi. Osteosarcoma receiving high dose Methotrexate vii. Germ cell tumors receiving Etoposide viii. Rhabdomyosarcoma ix. Ewing sarcoma
* Head/neck cancers receiving radiation
* Able to speak and understand English or Spanish
Exclusion Criteria:
* Unwilling to participate
* Do not meet eligibility criteria outline above
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
30 Years
Study:
NCT06623305
Study Brief:
Protocol Section:
NCT06623305